BioMarin Pharmaceutical Inc. was founded in 1997, and since July 1999 the company's common stock has been traded on both the Nasdaq National Market and SWX Swiss Exchange under the ticker symbol BMRN. BioMarin's policy is to fully comply with all rules put forth by the Securities and Exchange Commission, the Nasdaq National Market and the SWX Swiss Exchange. For misplaced stock certificates, please contact our transfer agent directly.